Intersection · Access × appeals
Access topics tagged appeals
Topics in Access carrying the tag appeals. Challenging a coverage denial, in writing, unemotionally.
19 topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Follow-up: Prior authorisation: what the criteria usually require
Prior authorisation: what the criteria usually require — setting out what I have, and where I think it stops being reliable. A methods question rather than a substantive one, about Prior authorisation.…
|
+95 | 100 | 9.1k | 10h |
|
Prior authorisation: what the criteria usually require — a second dataset
Posting this under the heading it deserves: Prior authorisation: what the criteria usually require — a second dataset Everything below is what sits behind that. Posting a small dataset on Prior authorisation.…
|
+67 | 74 | 19k | 21h |
|
Peer-to-peer review: what actually happens on the call
On the subject in the title: Peer-to-peer review: what actually happens on the call Working notes rather than a conclusion. The question about peer-to-peer review that I actually want answered is the second…
|
2 | 1.2k | 1d | |
|
An appeal that succeeded, with the letter structure
On the subject in the title: An appeal that succeeded, with the letter structure Working notes rather than a conclusion. Appeal, and specifically the version of it that the documentation does not cover. The…
|
+12 | 16 | 15k | 1d |
|
An appeal that succeeded, with the letter structure — the long version
An appeal that succeeded, with the letter structure — the long version — setting out what I have, and where I think it stops being reliable. A narrow question about appeal, deliberately narrow, because the…
|
+113 | 136 | 32k | 1mo |
|
External review after an internal denial
External review after an internal denial Writing it up because I had to work it out twice and would rather nobody else did. Proposing that external review deserves a maintained page rather than a recurring…
|
2 | 18k | 1mo | |
|
About the Insurance & coverage category
Prior authorisation, appeals, denial letters, and documentation that helps. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a…
|
+2 | 6 | 3.2k | 3mo |
|
Peer-to-peer review: what actually happens on the call — one year on
Peer-to-peer review: what actually happens on the call — one year on — setting out what I have, and where I think it stops being reliable. The question about Peer-to-peer review that I actually want answered…
|
+2 | 6 | 41k | 5mo |
|
Appeal templates and why they are deliberately unemotional
Posting this under the heading it deserves: Appeal templates and why they are deliberately unemotional Everything below is what sits behind that. A narrow question about appeal templates, deliberately narrow,…
|
+25 | 29 | 764 | 7mo |
|
Documentation that materially improves an appeal's chances
Documentation that materially improves an appeal's chances — setting out what I have, and where I think it stops being reliable. An honest uncertainty about documentation rather than a disguised assertion. I…
|
+93 | 98 | 3.6k | 8mo |
|
Revisiting: Reading a denial letter as a specification for your appeal
Posting this under the heading it deserves: Revisiting: Reading a denial letter as a specification for your appeal Everything below is what sits behind that. Asking about Reading a denial letter on behalf of…
|
+125 | 138 | 9.4k | 10mo |
|
Appeal templates and why they are deliberately unemotional — one year on
Appeal templates and why they are deliberately unemotional — one year on Writing it up because I had to work it out twice and would rather nobody else did. A narrow question about Appeal templates,…
|
2 | 4.1k | 11mo | |
|
Reading a denial letter as a specification for your appeal
Reading a denial letter as a specification for your appeal Writing it up because I had to work it out twice and would rather nobody else did. Reading back through what has been written here about reading a…
|
3 | 30k | 12mo | |
|
An appeal that failed, and what I would do differently
An appeal that failed, and what I would do differently Writing it up because I had to work it out twice and would rather nobody else did. Asking about appeal directly, because I have read four threads on it…
|
+4 | 8 | 125 | 12mo |
|
[2026 update] Documentation that materially improves an appeal's chances
On the subject in the title: Documentation that materially improves an appeal's chances Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…
|
2 | 2.4k | 13mo | |
|
Coverage for the indication versus for the drug
Coverage for the indication versus for the drug — setting out what I have, and where I think it stops being reliable. The question about coverage that I actually want answered is the second one below. The…
|
+70 | 79 | 18k | 14mo |
|
Coverage for the indication versus for the drug — a second dataset
On the subject in the title: Coverage for the indication versus for the drug — a second dataset Working notes rather than a conclusion. Posting a small dataset on Coverage. It is mine, it is uncontrolled, and…
|
+46 | 50 | 41k | 16mo |
|
Prior authorisation: what the criteria usually require
On the subject in the title: Prior authorisation: what the criteria usually require Working notes rather than a conclusion. I would like to know what people here actually do about prior authorisation, as…
|
+9 | 13 | 3.2k | 17mo |
|
[2026 update] Step therapy requirements and how to satisfy them
Step therapy requirements and how to satisfy them Writing it up because I had to work it out twice and would rather nobody else did. Something about Step therapy requirements does not reconcile and I would…
|
+111 | 122 | 3.4k | 18mo |
Sponsored
Janoshik Analytical — independent third-party testingHPLC purity and mass-spectrometric identity on submitted samples, reported with the method stated. The laboratory most often cited in this community’s verification records.Independent testing →
Sponsored
GL Biochem (Shanghai) Ltd. — synthesis, directFounded 1998. ISO 9001 and cGMP certified, over 1,500 staff and 200-plus patents. Custom peptide synthesis and amino acid derivatives, with a batch certificate on every order.Custom synthesis →